Coromandel International Limited — Important, 30-01-2025: Financial Result Updates

Coromandel International Limited reported robust financial performance for the quarter and nine months ended December 31, 2024. Total consolidated income reached ₹1,907.14 crore, marking a 17% year-on-year increase, driven by strong demand in the nutrient and allied business segments and effective market expansion strategies.

The company recorded a net profit of ₹700.15 crore, which is a significant increase compared to ₹319.76 crore in the previous year, translating to an EPS of ₹11.69 versus ₹5.39 year-on-year. This growth is attributed to improved operational efficiencies and better cost management despite rising raw material costs.

Total operational costs have risen by 11% to ₹1,207.99 crore, primarily due to higher procurement expenses. Nevertheless, effective cost management strategies helped the company mitigate the impact of these rising costs, reflecting positively on profitability.

The balance sheet remains strong, with total assets increasing to ₹20,096.95 crore, whereas total liabilities stood at ₹9,314.74 crore, indicating a healthy asset-liability ratio. Cash flows from operations have also shown resilience, providing ample liquidity for future investments.

Looking ahead, Coromandel appears focused on continuing its growth trajectory through strategic expansions, including plans for a wholly-owned subsidiary in Europe. Overall, given the company's strong financial metrics and strategic initiatives, there is a favorable outlook for investors, suggesting a hold position as it prepares for future growth opportunities.